XML 58 R47.htm IDEA: XBRL DOCUMENT v3.19.1
Business Segments (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Jun. 30, 2018
Segment Reporting Information [Line Items]          
Net sales $ 205,736 $ 208,908 $ 624,112 $ 608,196  
Depreciation and amortization 6,875 6,751 20,407 20,026  
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 19,515 24,388 62,294 64,543  
Interest expense, net 2,931 3,064 8,729 9,232  
Depreciation and amortization 6,875 6,751 20,407 20,026  
Stock-based compensation 565   1,694    
Acquisition-related cost of goods sold       1,671  
Acquisition-related accrued compensation       1,084  
Foreign currency (gains) losses, net 122 (960) 104 (958)  
Identifiable assets 706,420   706,420   $ 671,679
Animal Health          
Segment Reporting Information [Line Items]          
Net sales 129,189 132,310 399,940 393,996  
Mineral Nutrition          
Segment Reporting Information [Line Items]          
Net sales 60,653 62,938 177,810 174,627  
Performance Products          
Segment Reporting Information [Line Items]          
Net sales 15,894 13,660 46,362 39,573  
Operating Segments          
Segment Reporting Information [Line Items]          
Net sales 205,736 208,908 624,112 608,196  
Depreciation and amortization 6,436 6,220 19,050 18,413  
Adjusted EBITDA - Total segments 39,858 42,053 120,376 120,673  
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 19,515 24,388 62,294 64,543  
Interest expense, net 2,931 3,064 8,729 9,232  
Depreciation and amortization 6,436 6,220 19,050 18,413  
Stock-based compensation 565 0 1,694 0  
Acquisition-related cost of goods sold 0 0 0 1,671  
Acquisition-related accrued compensation 0 160 0 1,084  
Acquisition-related transaction costs 0 0 0 400  
Foreign currency (gains) losses, net 122 (960) 104 (958)  
Other 0 0 (1,506) 0  
Adjusted EBITDA - Total segments 39,858 42,053 120,376 120,673  
Identifiable assets 590,870   590,870   549,523
Operating Segments | Animal Health          
Segment Reporting Information [Line Items]          
Net sales 129,189 132,310 399,940 393,996  
Depreciation and amortization 5,571 5,359 16,420 15,878  
Adjusted EBITDA - Total segments 33,241 36,292 104,882 105,070  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 5,571 5,359 16,420 15,878  
Adjusted EBITDA - Total segments 33,241 36,292 104,882 105,070  
Identifiable assets 487,815   487,815   455,704
Operating Segments | Mineral Nutrition          
Segment Reporting Information [Line Items]          
Net sales 60,653 62,938 177,810 174,627  
Depreciation and amortization 592 584 1,805 1,753  
Adjusted EBITDA - Total segments 5,287 5,375 11,934 14,705  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 592 584 1,805 1,753  
Adjusted EBITDA - Total segments 5,287 5,375 11,934 14,705  
Identifiable assets 72,373   72,373   69,779
Operating Segments | Performance Products          
Segment Reporting Information [Line Items]          
Net sales 15,894 13,660 46,362 39,573  
Depreciation and amortization 273 277 825 782  
Adjusted EBITDA - Total segments 1,330 386 3,560 898  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 273 277 825 782  
Adjusted EBITDA - Total segments 1,330 386 3,560 898  
Identifiable assets 30,682   30,682   24,040
Corporate          
Segment Reporting Information [Line Items]          
Depreciation and amortization 439 531 1,357 1,613  
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 439 531 1,357 1,613  
Corporate costs 9,850 $ 8,650 28,654 $ 24,675  
Identifiable assets $ 115,550   $ 115,550   $ 122,156